REGN- thanks Dew. This is what makes a market. I believe in the value of VEGF as the clinical data continues to unfolds. I don't only look at the data, but also the quality of REGN's management and their partnerships.
Since Nov 06 I'm up 500% on my principle through strategic use of margin, and I hope my trend continues. fyi, I'm out of IDIX for now, with most of my portfolio focused on RPRX, REGN, and a lesser amount on DNDN.
Good luck,
Spartex